Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2025)
Cellebrite DI's Total Current Liabilities history spans 6 years, with the latest figure at $369.7 million for Q4 2025.
- Quarterly Total Current Liabilities rose 25.09% to $369.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $369.7 million through Dec 2025, up 25.09% year-over-year, with the annual reading at $369.7 million for FY2025, 25.09% up from the prior year.
- Total Current Liabilities came in at $369.7 million for Q4 2025, up from $316.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $403.7 million in Q3 2021 to a low of $170.6 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $235.9 million (2024), against an average of $252.5 million.
- Year-over-year, Total Current Liabilities tumbled 52.99% in 2022 and then surged 30.66% in 2025.
- Cellebrite DI's Total Current Liabilities stood at $186.6 million in 2021, then rose by 11.36% to $207.8 million in 2022, then rose by 22.16% to $253.8 million in 2023, then rose by 16.42% to $295.5 million in 2024, then rose by 25.09% to $369.7 million in 2025.
- Per Business Quant, the three most recent readings for CLBT's Total Current Liabilities are $369.7 million (Q4 2025), $316.9 million (Q3 2025), and $310.0 million (Q2 2025).